Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Aptose Biosciences | APTO | Jan 14, 2025 | 0.20 | -4.02 |
APx Acquisition I Unit | APXIU | Jan 14, 2025 | 11.55 | 0.00 |
Apyx Medical | APYX | Jan 14, 2025 | 1.43 | -4.03 |
Aqua Metals | AQMS | Jan 14, 2025 | 2.06 | -0.96 |
AquaBounty Technologies | AQB | Jan 14, 2025 | 0.77 | +3.89 |
Aquaron Acquisition | AQU | Jan 14, 2025 | 12.04 | 0.00 |
Aquaron Acquisition Units | AQUNU | Jan 14, 2025 | 11.95 | 0.00 |
Aquestive Therapeutics | AQST | Jan 14, 2025 | 3.05 | -1.93 |
Aramark | ARMK | Jan 14, 2025 | 38.22 | +1.19 |
ARB IOT Group | ARBB | Jan 14, 2025 | 0.56 | -6.07 |
Arbe Robotics | ARBE | Jan 14, 2025 | 3.00 | +7.14 |
Arbor Realty Trust | ABR | Jan 14, 2025 | 13.30 | +1.06 |
Arbor Realty Trust D Pref | ABR-D | Jan 14, 2025 | 18.90 | +0.89 |
Arbor Realty Trust E Pref | ABR-E | Jan 14, 2025 | 18.55 | +1.53 |
Arbor Realty Trust F Pref | ABR-F | Jan 14, 2025 | 22.49 | +0.76 |
Arbutus Biopharma | ABUS | Jan 14, 2025 | 3.18 | -5.07 |
Arcadia Biosciences | RKDA | Jan 14, 2025 | 4.90 | +1.03 |
Arcadium Lithium | ALTM | Jan 14, 2025 | 5.70 | 0.00 |
ArcBest | ARCB | Jan 14, 2025 | 100.50 | +4.08 |
Arcellx | ACLX | Jan 14, 2025 | 64.65 | -4.02 |
Arcelor Mittal ADR | MT | Jan 14, 2025 | 22.44 | +0.67 |
Arch Capital F Pref | ACGLO | Jan 14, 2025 | 20.86 | +0.34 |
Arch Capital G | ACGLN | Jan 14, 2025 | 17.62 | +0.11 |
Arch Capital Group | ACGL | Jan 14, 2025 | 91.99 | +1.28 |
Arch Resources A | ARCH | Jan 14, 2025 | 134.83 | 0.00 |
Archer Aviation A | ACHR | Jan 14, 2025 | 8.22 | -0.12 |
Archer Daniels Midland | ADM | Jan 14, 2025 | 51.19 | -1.78 |
Archrock | AROC | Jan 14, 2025 | 28.58 | +6.05 |
Arcos Dorados | ARCO | Jan 14, 2025 | 7.37 | -1.73 |
Arcosa | ACA | Jan 14, 2025 | 96.13 | +3.41 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.